Sign in
CompletedNo phase

The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy

Key facts

Who runs it
Affiliated Hospital of Nantong University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
84 people enrolled
Started
17 Jan 2025
Ended
31 Oct 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Transcutaneous Auricular Vagus Nerve Stimulator
Record updated
1 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Age ≥18 years
  • Diagnosed with pancreatic tumors or periampullary tumors by imaging or pathology and scheduled for pancreaticoduodenectomy
  • No distant metastases and tumors are resectable
  • Classified as American Society of Anesthesiologists (ASA) physical status I to III
  • Capable of understanding the study procedures and various assessment scales and able to effectively communicate with the researchers
  • Willing to participate in the study and provide written informed consent

Who cannot take part

  • Patients who have undergone chemotherapy or radiotherapy before surgery
  • Patients with implanted stimulators (e.g., pacemakers, implanted vagus nerve stimulators, deep brain stimulators, spinal cord stimulators), cochlear implants, or metallic implants (excluding dental work)
  • Patients who recently used prokinetic agents, cholinergic or anticholinergic drugs, or hormones
  • Patients who received vagus nerve stimulation or acupuncture within 1 month before the study
  • Patients with other malignant tumors
  • Patients with a history of gastrectomy or other gastric surgeries
  • Patients diagnosed with chronic gastrointestinal inflammation, peptic ulcers, or a history of gastroparesis, pyloric, or other gastrointestinal obstructions
  • Patients with a history of autonomic dysfunction (e.g., peripheral neuropathy, vagotomy, thyroid dysfunction, amyloidosis, asthma, heart failure, renal dysfunction, or alcoholism)
  • Patients with skin damage or dermatological conditions at the stimulation site
  • Patients with a preoperative heart rate below 60 beats per minute
  • Patients with chronic organ dysfunction
  • Patients unable to cooperate with assessments
  • Patients participating in other clinical trials

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the effects of transcutaneous auricular vagus nerve stimulation (taVNS) during the perioperative period on the incidence of delayed gastric emptying after pancreatoduodenectomy and its possible mechanisms.

The 2 groups in the trial

  • Transcutaneous auricular vagus nerve stimulation (taVNS group)Treatment being tested

    Patients in the taVNS group will have a transcutaneous auricular vagus nerve stimulation device with a transparent, non-insulated thin film placed on the cymba conchae of the left ear. TaVNS will be administered on the day of surgery (starting 30 minutes before anesthesia induction and continuing until the end of the surgery, terminating after the removal of the endotracheal tube in the PACU). The stimulation parameters are set as follows: frequency 25 Hz, pulse width 200 μs, 30 seconds on / 30 seconds off, with the current intensity set to the maximum amplitude the patient can tolerate (just below the pain threshold).

    Treatment: Transcutaneous Auricular Vagus Nerve Stimulator

  • Sham transcutaneous auricular vagus nerve stimulation (Sham taVNS group)No study treatment, for comparison

    Patients in the Sham taVNS group will have a transcutaneous auricular vagus nerve stimulation device with a transparent insulating film placed on the cymba conchae of the left ear on the day of surgery. The stimulation parameters, method, and duration will be the same as those in the taVNS group. However, due to the insulating film applied to the stimulation device in the sham group, patients will not actually receive any stimulation.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on the Incidence of Delayed Gastric Emptying After Pancreatoduodenectomy: A Randomized Controlled Trial
Record updated
1 September 2026